复方蒿甲醚国际合作的回顾与思考

Review and Consideration of International Cooperation in Compound Artemether

本文通过回顾15年来中国发明的专利药品复方蒿甲醚的国际合作历程及其对于中国药物研究开发的启示认为:复方蒿甲醚在当时的历史背景下率先从国内标准提高到国际认可标准并获得极高的国际知名度,是与成功的国际科技合作密不可分。15年来,中国经济体系逐步与世界经济体系融合,国内专利体制、医药体制及相关技术标准迅速与国际接轨的过程促使我国医药行业对于医药产品研发创新、专利保护、临床试验、注册销售和规范化管理的思想认识完成了质的跨越,并已成为融入行业文化的一种思维和管理方式。复方蒿甲醚国际科技合作的经验和教训给予我们的启示说明:创新是药品的生命之本,国际化战略是中国医药产业发展的关键。

By reviewing the course of the international cooperation in the patented medicine compound artemether of Chinese invention in the past 15 years and the enlightenment conferred to the study and development of medicines in China in the course, the article holds that the success that compound artemether could have its standard first raised in the country to an international standard from a domestic one and win great popularity in the world under the historical background of that time, are inseparable from the successful international cooperation. In the 15 years the situation that the economic system of China has gradually mixed together with that of the world and the patent and medical systems and their related technical standards have rapbidly dovetailed with those of the world has brought about a substantial leap forward of the thinking and knowledge in the study, development and innovation, the protection of patents, the clinical experiments, the registration and sale of medical products and the standardized management of all these links in the medical industry of the country. This is a thinking and management mode which have merged into the culture of this industry. The enlightenment that experience and lessons have taught us makes it clear that innovation is the foundation of the life of medicaments and international strategy forms the key to the development of medical industry of China.